A SPECT/NIR Fluorescence Dual-Modality Imaging Agent Composed of Drugs and Hospital Available Isotope for Preoperative Sentinel Lymph Node Mapping and Intraoperative Biopsy
Ming Zhou,Peng Liu,Xiaoqin Yin,Caiting Deng,Yi Xiao,Meng Lei,Shuo Hu,Feifei An,Min Zhao
DOI: https://doi.org/10.2147/ijn.s430502
IF: 7.033
2023-12-14
International Journal of Nanomedicine
Abstract:Ming Zhou, 1, 2, &ast Peng Liu, 1, 2, &ast Xiaoqin Yin, 1 Caiting Deng, 3, 4 Yi Xiao, 1 Meng Lei, 1 Shuo Hu, 1 Feifei An, 3 Min Zhao 1, 5, 6 1 Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China; 2 Key Laboratory of Biological, Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha, People's Republic of China; 3 School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China; 4 Institute of Medical Engineering, Department of Biophysics, School of Basic Medical Science, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China; 5 Department of Nuclear Medicine, Third Xiangya Hospital, Central South University, Changsha, People's Republic of China; 6 National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People's Republic of China &astThese authors contributed equally to this work Correspondence: Min Zhao; Feifei An, Email ; Background: Sentinel lymph node (SLN) mapping-guided biopsy is crucial for cancer staging and treatment. Optical/nuclide dual-modality imaging agents for mapping SLN are ideal for preoperative planning and intraoperative biopsy, which are enabled by penetration-depth unlimited nuclide imaging and dynamic real-time optical imaging, respectively. However, commonly reported dual-modality imaging agents are composed of novel but safety-unproven materials, making their quick clinical translation challenging. Herein, we report a novel nanoparticle composed of facile hospital-available drugs and isotope for single-photon emission computed tomography (SPECT)/near-infrared (NIR) fluorescence imaging to detect SLNs. Methods: Indocyanine green-human serum albumin (ICG-HSA) nanoparticles (NPs) were synthesized by ICG-induced HSA self-assembly and further 99m Tc-labeling via a one-step, facile hospital-available method. After injecting 99m Tc-ICG-HSA into the rats' forepaw pads, the rats' draining axillary lymph nodes were visualized by preoperative mapping with SPECT/CT and intraoperative biopsy with NIR fluorescence. The axillary lymph nodes of rats were identified by pathology and fluorescent staining after execution. Additionally, its toxicity testing and comparison with 99m Tc-sulfur colloid imaging were also explored. Results: The study reported a self-assembled 99m Tc-ICG-HSA with a high radiochemical yield (85.6 ± 3.8%). Compared with conventional 99m Tc-sulfur colloid, 99m Tc-ICG-HSA NPs showed faster SLN identification, higher renal clearance, and lower hepatic retention. Furthermore, NIRF imaging allowed for the accurate visualization of the SLN and guided SLN biopsy intraoperatively. Notably, the 99m Tc-ICG-HSA NPs were composed of hospital-available drugs and isotope, which are safe for acute toxicity evaluation by a certified institute. Conclusion: The proposed 99m Tc-ICG-HSA NPs are safe and capable of noninvasive SLN identification and biopsy guidance with multi-modal imaging strategies and could be a promising tool for clinically assisted SLN biopsy. Keywords: image-guided surgery, indocyanine green, albumin, fluorescence imaging, near-infrared, single-photon emission computed tomography Graphical Cancer is currently the leading cause of premature death and the only cure for early-stage cancer is to remove as much of the primary tumor and regional lymph node (LN) as possible, along with the margins of normal tissue. 1–3 Previous studies have shown that prophylactic extended lymphadenectomy has no apparent survival benefit for cancer patients, and this approach is associated with a higher risk of complications such as lymphedema, dysfunction, and pain that reduce quality of life. 4–8 The sentinel lymph node (SLN) is the first site that receives lymphatic drainage from the primary tumor site. 9 In any type of malignant tumor, the most accurate LN staging methods include SLN mapping, surgical resection, and pathological examination. 10,11 Therefore, SLN biopsy (SLNB) has been recognized as an important technique in various cancer surgeries. 12–14 At present, the primary clinical methods for accurate SLN imaging and localization are optical imaging, naked eye observation with blue dye or near-infrared fluorescence (NIRF) imaging with indocyanine green (ICG), and radioisotope imaging. 15, -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology